Studies exercise effects on vitamin D treatment in adults with type 2 diabetes
Tests resistance training alongside aerobic training in adults with type 2 diabetes.
Plain-language title generated from the registry record
Registry title: The Effect of Aerobic and Resistance Training in Patients With Type 2 Diabetes on Vitamin D Treatment
Key facts
- Where
- Barcelona, SpainSee the site
Where in Spain
- CAP Sant RafaelBarcelona, SpainTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Ramon Llull
- Trial code
- NCT06081387
- Record updated
- 6 August 2025
- Original description
The purpose of this study protocol is to assess the effect of concurrent aerobic and resistance training in patients with type 2 diabetes on vitamin D treatmentRead full original descriptionShow less
The Effect of Aerobic and Resistance Training in Patients With Type 2 Diabetes on Vitamin D Treatment: the DIAVITEX Project
The purpose of this study protocol is to assess the effect of concurrent aerobic and resistance training in patients with type 2 diabetes on vitamin D treatment
Inclusion: Adults (females or males) older than 18 years old with a diagnosis of T2D in the clinic database; Patients who have been taking the combination therapy of metformin + sodium-glucose transport protein 2 inhibitors (iSGLT2), as recommended by the redGDPS 2023, with stable medication for the past 6 months; Diabetic patients taking prescribed VitD treatment for at least 6 months (intervention group) and diabetic patients not taking prescribed VitD (control group); Patients who signed the informed consent; Patients capable of performing mild to moderate physical activity (to walk steadily and independently for at least 6 minutes).
Exclusion: Patients taking other medication different than metformin + iSGLT2 (including combinations and insulin); Patients taking polyvitaminic supplementation at the inclusion for at least, 1 month before the intervention; Female subjects who are pregnant; Patients who did not sign the informed consent.